U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 160

1.
Prevalence and associated factors of premenstrual dysphoric disorder among high school students in Finote Selam town, northwest Ethiopia
Getasew Kibralew, Demeke Demilew, Selam Koye, Sewbesew Yitayih, Mulualem Kelebie, Mamaru Melkam, Gebresilassie Tadesse, Setegn Fentahun, Girum Nakie, Yilkal Abebaw Wassie, Tadele Amare
Front Psychiatry. 2024; 15: 1362118. Published online 2024 Jun 21. doi: 10.3389/fpsyt.2024.1362118
PMCID:
PMC11234160
AbstractArticlePDF–698K
2.
Peripheral Blood Mononuclear Cell Expression of Cation-Chloride Cotransporter (CCC) Genes in Premenstrual Dysphoric Disorder (PMDD) across the Menstrual Cycle—A Preliminary Study
Soojeong Cho, Fatimata Soumare, Sunni L. Mumford, Paola C. Rosas, Zarema Abrieva, John M. Davis, Ajna Hamidovic
Biology (Basel) 2024 Jun; 13(6): 377. Published online 2024 May 25. doi: 10.3390/biology13060377
PMCID:
PMC11201072
AbstractArticlePDF–536K
3.
Symptoms of premenstrual dysphoric disorder and cycle phase are associated with enhanced facial emotion detection: An online cross-sectional study
Bianca Boboc, Kirsten A Oinonen
Womens Health (Lond) 2024; 20: 17455057241259176. Published online 2024 Jun 14. doi: 10.1177/17455057241259176
PMCID:
PMC11179547
AbstractArticlePDF–1.0M
4.
Response to sertraline is associated with reduction in anxiety-potentiated startle in premenstrual dysphoric disorder
Liisa Hantsoo, Christian Grillon, Mary Sammel, Rachel Johnson, Joanna Marks, C. Neill Epperson
Psychopharmacology (Berl) Author manuscript; available in PMC 2024 Jun 3.
Published in final edited form as: Psychopharmacology (Berl). 2021 Oct; 238(10): 2985–2997. Published online 2021 Jul 22. doi: 10.1007/s00213-021-05916-6
PMCID:
PMC11146287
AbstractArticlePDF–650K
5.
Determinants of premenstrual dysphoric disorder and associated factors among regular undergraduate students at Hawassa University Southern, Ethiopia, 2023: institution-based cross-sectional study
Aklile Tsega Chekol, Yared Reta, Fikadu Ayinewa, Lielina Hailu, Mulualem Tesema, Mastewal Aschale Wale
BMC Public Health. 2024; 24: 1390. Published online 2024 May 23. doi: 10.1186/s12889-024-18798-y
PMCID:
PMC11119308
AbstractArticlePDF–1.7M
6.
Premenstrual dysphoric disorder and associated factors among university graduating class female students in Ethiopia: A cross-sectional study
Tilahun Abdeta, Dawit Firdisa, Abiy Mulugeta, Jerman Dereje
SAGE Open Med. 2024; 12: 20503121241241219. Published online 2024 May 22. doi: 10.1177/20503121241241219
PMCID:
PMC11113024
AbstractArticlePDF–484K
7.
Visuospatial Function in Women with Premenstrual Dysphoric Disorder
Ajna Hamidovic, Soojeong Cho, Shahd Smadi, John Davis
J Clin Med. 2024 Apr; 13(7): 2004. Published online 2024 Mar 29. doi: 10.3390/jcm13072004
PMCID:
PMC11012488
AbstractArticlePDF–819K
8.
Blunted Cortisol Response to Acute Psychosocial Stress in Women With Premenstrual Dysphoric Disorder
Ajna Hamidovic, John Davis, Fatimata Soumare
Int J Neuropsychopharmacol. 2024 Mar; 27(3): pyae015. Published online 2024 Mar 7. doi: 10.1093/ijnp/pyae015
PMCID:
PMC10965026
AbstractArticlePDF–953K
9.
Prämenstruelles Syndrom und prämenstruelle dysphorische Störung – Übersicht zu Pathophysiologie, Diagnostik und Therapie
Jana Haußmann, M. Goeckenjan, R. Haußmann, P. Wimberger
Nervenarzt. 2024; 95(3): 268–274. German. Published online 2024 Feb 23. doi: 10.1007/s00115-024-01625-5
PMCID:
PMC10914875
AbstractArticlePDF–392K
10.
Diagnostic validity of premenstrual dysphoric disorder: revisited
Shalini S. Naik, Yadav Nidhi, Krishan Kumar, Sandeep Grover
Front Glob Womens Health. 2023; 4: 1181583. Published online 2023 Nov 27. doi: 10.3389/fgwh.2023.1181583
PMCID:
PMC10711063
AbstractArticlePDF–887K
11.
Late Luteal Subphase Food Craving Is Enhanced in Women with Obesity and Premenstrual Dysphoric Disorder (PMDD)
Ajna Hamidovic, Shahd Smadi, John Davis
Nutrients. 2023 Dec; 15(23): 5000. Published online 2023 Dec 2. doi: 10.3390/nu15235000
PMCID:
PMC10707764
AbstractArticlePDF–818K
12.
Premenstrual Syndrome and Premenstrual Dysphoric Disorder’s Impact on Quality of Life, and the Role of Physical Activity
Fabrizio Liguori, Emma Saraiello, Patrizia Calella
Medicina (Kaunas) 2023 Nov; 59(11): 2044. Published online 2023 Nov 20. doi: 10.3390/medicina59112044
PMCID:
PMC10673441
AbstractArticlePDF–301K
13.
Childhood adversity predicts stronger premenstrual mood worsening, stress appraisal and cortisol decrease in women with Premenstrual Dysphoric Disorder
Sibel Nayman, Isabelle Florence Schricker, Iris Reinhard, Christine Kuehner
Front Endocrinol (Lausanne) 2023; 14: 1278531. Published online 2023 Nov 2. doi: 10.3389/fendo.2023.1278531
PMCID:
PMC10653441
AbstractArticlePDF–692K
14.
Testosterone and Prolactin Perturbations Possibly Associated with Reduced Levels of β-Arrestin1 in Mononuclear Leukocytes of Women with Premenstrual Dysphoric Disorder
Sanket Nayyar, Anthony Archibong, Tultul Nayyar
Int J Mol Sci. 2023 Oct; 24(20): 15449. Published online 2023 Oct 22. doi: 10.3390/ijms242015449
PMCID:
PMC10607656
AbstractArticlePDF–2.7M
15.
Significance and Interrelationship of the Symptoms Listed in the DSM Criteria for Premenstrual Dysphoric Disorder
Erik Studer, Staffan Nilsson, Anna Westman, Nancy L. Pedersen, Elias Eriksson
Psychiatr Res Clin Pract. 2023 Autumn; 5(3): 105–113. Published online 2023 May 17. doi: 10.1176/appi.prcp.20220007
PMCID:
PMC10499188
AbstractArticlePDF–945K
16.
Effects of cognitive emotion regulation strategies on mood and cortisol in daily life in women with premenstrual dysphoric disorder
Sibel Nayman, Theresa Beddig, Iris Reinhard, Christine Kuehner
Psychol Med. 2023 Aug; 53(11): 5342–5352. Published online 2022 Aug 18. doi: 10.1017/S0033291722002495
PMCID:
PMC10476072
AbstractArticlePDF–314K
17.
Does Symptom-Onset Treatment with a Sertraline Improve Functional Impairment for Individuals with Premenstrual Dysphoric Disorder: A Randomized Controlled Trial
Kimberly A. Yonkers, Margaret Altemus, Kathryn Gilstad-Hayden, Susan G. Kornstein, Ralitza Gueorguieva
J Clin Psychopharmacol. Author manuscript; available in PMC 2024 May 22.
Published in final edited form as: J Clin Psychopharmacol. 2023 Jul-Aug; 43(4): 320–325. Published online 2023 May 22. doi: 10.1097/JCP.0000000000001700
PMCID:
PMC10313784
AbstractArticlePDF–485K
18.
The prevalence of moderate–severe premenstrual syndrome and premenstrual dysphoric disorder and the related factors in high school students: A cross‐sectional study
Farzaneh Babapour, Forouzan Elyasi, Zohreh Shahhosseini, Monirolsadate Hosseini Tabaghdehi
Neuropsychopharmacol Rep. 2023 Jun; 43(2): 249–254. Published online 2023 May 8. doi: 10.1002/npr2.12338
PMCID:
PMC10275287
AbstractArticlePDF–320K
19.
New Pharmacological Approaches to the Management of Premenstrual Dysphoric Disorder
Inger Sundström-Poromaa, Erika Comasco
CNS Drugs. 2023; 37(5): 371–379. Published online 2023 May 12. doi: 10.1007/s40263-023-01004-9
PMCID:
PMC10212816
AbstractArticlePDF–609K
20.
Exploring diagnosis and treatment of premenstrual dysphoric disorder in the U.S. healthcare system: a qualitative investigation
Kiera Chan, Anna A. Rubtsova, Cari Jo Clark
BMC Womens Health. 2023; 23: 272. Published online 2023 May 17. doi: 10.1186/s12905-023-02334-y
PMCID:
PMC10193729
AbstractArticlePDF–1.3M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center